A Comparison of Total Knee Replacement Patients Using the Zimmer-Biomet Persona Total Knee System With Different Inserts
A Prospective Randomised, Controlled Clinical Trial to Compare the Functional Outcomes of Patients Undergoing Total Knee Replacement Using the Zimmer-Biomet Persona Total Knee System With Cruciate-Retaining or Medial Congruent Bearings
1 other identifier
interventional
120
1 country
1
Brief Summary
As demand for knee joint arthroplasties surge, improving long term patients' satisfaction and implant survivorship has become of utmost importance, as patients seek not only to alleviate their condition, but also return to their usual daily activities and sports. Implant type and design plays an important role in this, with many modern designs seeking to replicate the native knee's kinematics and alignment through mimicry of native knee biomechanics in its femoral components, tibial components, and polyethylene bearing inserts. The Zimmer-Biomet Persona® Total Knee Cruciate-Retaining Femoral Component (CR Femur), used in conjunction with the kinematic alignment surgical technique, has been shown to produce better functional outcomes and improved patient satisfaction following total knee arthroplasty. More recently, Zimmer-Biomet introduced the Medial Congruent Bearing (MC Bearing) design to be used with the CR Femur; the design facilitates greater stability through increased anterior lip height compared to the original Cruciate Retaining Bearing (CR Bearing), thus allowing for greater anterior constraint and subluxation resistance that aids in activities requiring deeper flexion or full extension. However, the evidence that this will lead to better patient satisfaction and function is scarce, and requires further study to prove that the MC Bearing is a better insert choice to recommend to both surgeons and patients alike. 120 patients from Singapore General Hospital seeking primary total knee replacement surgery will be recruited for this study, and randomised in a 1:1 ratio to receive either the CR Bearing or the MC Bearing alongside the Zimmer-Biomet CR Femur implant. They will be followed up for two years post-operatively, and their outcomes recorded at specific milestones to be analysed for the impact of insert design on knee function, patient satisfaction and quality of life post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2020
CompletedFirst Posted
Study publicly available on registry
November 24, 2020
CompletedStudy Start
First participant enrolled
April 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedMarch 23, 2021
March 1, 2021
2.3 years
October 25, 2020
March 21, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Comparison of Oxford Knee Scores between treatment groups
Differences in total Oxford Knee Scores between the two treatment groups will be compared at 1-month, 3-months, 6-months, 12-months and 24-months post-operatively.
2 years
Comparison of Knee Society Rating Scores between treatment groups
Differences in total Knee Society Rating Scores between the two treatment groups will be compared at 1-month, 3-months, 6-months, 12-months and 24-months post-operatively.
2 years
Comparison of Forgotten Joint Scores between treatment groups
Differences in total Forgotten Joint- 12 Item Scores between the two treatment groups will be compared at 1-month, 3-months, 6-months, 12-months and 24-months post-operatively.
2 years
Comparison of UCLA Activity scores between treatment groups
Differences in total UCLA Activity scores between the two treatment groups will be compared at 1-month, 3-months, 6-months, 12-months and 24-months post-operatively.
2 years
Secondary Outcomes (3)
Comparison of discharge times between treatment groups
2 years
Comparison of quality of life between treatment groups
2 years
Comparison of gait in pre-operative and post-operative state
2 years
Study Arms (2)
Cruciate-Retaining Insert
ACTIVE COMPARATORMedial-Congruent Insert
EXPERIMENTALInterventions
The Medial Congruent Bearing (MC Bearing) design was introduced in 2016 for use with the Zimmer-Persona Cruciate-Retaining Femur: the design facilitates greater stability through increased anterior lip height compared to the original Cruciate Retaining Bearing (CR Bearing), allowing for greater anterior constraint and subluxation resistance that aids in full extension and deep flexion. Furthermore, the MC Bearing has been suggested for use in patients presenting with more complicated surgical histories (e.g prior high tibial osteotomies or patellectomies), whereas the original CR Bearing is strictly suggested for use only in patients undergoing knee surgery for the first time, where the posterior cruciate ligament may still be intact.
The Cruciate-Retaining Bearing (CR Bearing) design was launched together with the use of the Cruciate-Retaining Femoral Components (CR Femur) of the Zimmer-Biomet Persona® Total Knee system. The design not only stabilises the knee through medial conformity and anterior constraint, but also allows for freer and more natural deep flexion through freer movement of the lateral condyle.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with, or are experiencing knee osteoarthritis
- Patients considered fit and appropriate for TKA surgical intervention
- Patients between 50-80 years of age at time of surgery
- Patients of Chinese, Malay, or Indian ethnicity (combination of the three groups are accepted)
- Patient must be capable of giving informed consent and agree to comply with the postoperative review programme
- Patients who will stay in Singapore for up to two years post-surgery
- Patients should have sufficient postoperative mobility to attend follow-up clinics and allow for radiographs to be taken
- Female patients should be post-menopausal, or be willing to take contraceptives/birth control measures throughout study
You may not qualify if:
- Patients not suitable for routine primary TKA e.g. patient has ligament deficiency that requires a constrained prosthesis
- Patient has bone loss that requires augmentation
- Patients determined medically unfit for surgical intervention
- Patients who had prior knee replacement surgery done for the symptomatic limb
- Patients with impaired musculoskeletal function
- Patients less than 50 years of age or greater than 80 years of age
- Patients enrolled on another concurrent clinical trial
- Patients who are not local residents, or do not intend to stay in Singapore after surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore General Hospital
Singapore, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lincoln Liow
Singapore General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Patients are randomised to 2 different treatment groups by a study team member who will not participate in final data analysis; only their surgeon and the clinical team will be aware of the treatment the patient undergoes. Treatment codes will be used to indicate the patient's treatment assignment in study-related documents, and clinical documents will reference their treatment code as well. Radiological, functional and strength assessments will be conducted by non-study clinical staff who will not be aware of the patient's treatment group. Analysis will be conducted by a statistician who is uninvolved in the recruitment and data collection process, and only upon completion will the treatment arms will be unblinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2020
First Posted
November 24, 2020
Study Start
April 26, 2021
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
March 23, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share